The National Musculoskeletal Audit and Research Database

February 4, 2026 updated by: Keele University

Developing and Testing a Musculoskeletal National Audit in Community/Primary Care

Developing and testing a musculoskeletal national audit in community/primary care

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This project aims to develop, setup and test an MSK national audit which will use patient and clinician inputted data to measure the quality of care for patients presenting in community MSK services and general practice with common MSK conditions. Secondly this project aims to use the national MSK audit information to understand and improve the quality and consistency of care for MSK patients.

Study Type

Observational

Enrollment (Estimated)

22000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Staffordshire
      • Keele, Staffordshire, United Kingdom, ST5 5BG
        • Recruiting
        • Keele University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jonathan Hill, Prof
        • Sub-Investigator:
          • Roanna Burgess, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

22,000 adult patients (over 2-year period), aged 18+ years consulting a) a Community MSK Service or b) a First Contact Practitioner (FCP) service in primary care, for a musculoskeletal pain condition

Description

Inclusion Criteria:

(MSK Services)

  • MSK service seeing adult (+18 years) set in community care
  • MSK service with at least 10 WTE HCPs
  • System in place for digital collection of PROM/PREM data

(FCP Services)

  • FCP service seeing adult (+18 years) in primary care
  • FCP service with at least 1 WTE FCP seeing MSK patients
  • Use of EMIS or SYSTMONE
  • Able to implement Midlands FCP template
  • System in place for digital collection of PROM/PREM data

(For patients)

  • +18 years
  • Active phone number or verified email address to participate in the patient questionnaire
  • Able to provide informed consent

Exclusion Criteria:

(MSK Services)

* Secondary care MSK services

(For patients)

  • Has declined for data to be part of research as part of consent process
  • Unable to complete surveys due to health issues including severe or terminal illness, severe learning difficulties or psychological disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
First Contact Practitioner (FCP)

A continuous routine-data cohort study involving FCP primary care services aiming to recruit a minimum of 25patients per service from 10 FCP services, with complete data from at least 25 patients at baseline and 3-month follow up per service for each 12-month period. Data collection will involve:

Patient survey (to collect outcomes and experiences)

Organisational characteristics (collected via a survey to service leads and via publicly available national sources)

Electronic health record (EHR) data (collected via a standardised FCP template and search within EHR systems)

Baseline and 3 month questionnaire
MSK Community Services

A continuous routine-data cohort study involving MSK Community Services, aiming to recruit a minimum of 250 patients per service from a minimum of 10 MSK services, with complete data from at least 250 patients at baseline and 3-month follow up per service for each 12-month period. Data collection will involve:

Patient survey (to collect outcomes and experiences)

Organisational characteristics (collected via a survey to service leads and via publicly available national sources)

Baseline and 3 month questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To provide a secure national MSK research database for participating MSK providers to upload their routinely collected data.
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
To develop a standard dashboard and reporting system that supports an ongoing automated process to analyse and present the data for quality improvement purposes.
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2024

Primary Completion (Estimated)

June 7, 2028

Study Completion (Estimated)

June 7, 2028

Study Registration Dates

First Submitted

April 24, 2023

First Submitted That Met QC Criteria

April 24, 2023

First Posted (Actual)

May 6, 2023

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

Clinical Trials on Questionnaire

Subscribe